May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Mutation–Independent suppression of rhodopsin in Autosomal dominant Retinitis Pigmentosa by siRNA.
Author Affiliations & Notes
  • T.C. Cronin
    Genetics, Trinity College Dublin, Dublin, Ireland
  • M. O'Reilly
    Genetics, Trinity College Dublin, Dublin, Ireland
  • B. O'Neill
    Genetics, Trinity College Dublin, Dublin, Ireland
  • A.–S. Kiang
    Genetics, Trinity College Dublin, Dublin, Ireland
  • A. Palfi
    Genetics, Trinity College Dublin, Dublin, Ireland
  • P.F. Kenna
    Genetics, Trinity College Dublin, Dublin, Ireland
  • G.J. Farrar
    Genetics, Trinity College Dublin, Dublin, Ireland
  • P. Humphries
    Genetics, Trinity College Dublin, Dublin, Ireland
  • Footnotes
    Commercial Relationships  T.C. Cronin, None; M. O'Reilly, None; B. O'Neill, None; A. Kiang, None; A. Palfi, None; P.F. Kenna, None; G.J. Farrar, None; P. Humphries, None.
  • Footnotes
    Support  Enterprise Ireland grant
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 5150. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T.C. Cronin, M. O'Reilly, B. O'Neill, A.–S. Kiang, A. Palfi, P.F. Kenna, G.J. Farrar, P. Humphries; Mutation–Independent suppression of rhodopsin in Autosomal dominant Retinitis Pigmentosa by siRNA. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):5150.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To monitor suppression levels of human rhodopsin transcript treated with a range of siRNAs and compare it to expression levels of a replacement rhodopsin gene with altered target sites. Methods: Cos7 cells expressing human rhodopsin were treated with siRNA. Transcript RNA and protein levels were assessed by quantitative rt–PCR and western blotting respectively. Results: Wild–type rhodopsin transcript can be suppressed without affecting expression of an altered rhodopsin message that codes for the same amino acids but has some alternative degenerate base–pair target sites. Conclusions: We have identified agents with potential as suppression components in a suppression and replacement therapeutic strategy.

Keywords: retinal degenerations: hereditary • gene/expression • gene transfer/gene therapy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×